Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking method to diabetes management. These innovative medications operate by mimicking the physiological actions of GLP-1, a hormone released https://reallivesocial.com/story6422551/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes